# Cysteine Supplementation in Critically Ill Neonates

> **NCT00254176** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of California, Los Angeles** · enrollment: 108 (estimated)

## Conditions studied

- Sepsis
- Bronchopulmonary Dysplasia
- Necrotizing Enterocolitis
- Retinopathy of Prematurity
- Systemic Inflammatory Response Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Parenteral cysteine-HCl supplementation
- **DIETARY_SUPPLEMENT:** Placebo - added premasol

## Key facts

- **NCT ID:** NCT00254176
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-07
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2010-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00254176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00254176, "Cysteine Supplementation in Critically Ill Neonates". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00254176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*